No ke aha ʻoi aku ka maikaʻi o ka Needle-free Injector?

I kēia manawa, aia ma kahi o 114 miliona mau maʻi maʻi maʻi maʻi ma Kina, a ma kahi o 36% o lākou e pono ai i ka insulin injections. Ma waho aʻe o ka ʻeha o nā lāʻau nila i kēlā me kēia lā, ke alo nei lākou i ka induration subcutaneous ma hope o ka hoʻoiho ʻana i ka insulin, nā ʻōpala a me nā nila haki a me ka insulin. ʻO ke kūʻē maikaʻi ʻole i ka absorption alakaʻi i ke kō koko koko. ʻO kekahi poʻe maʻi makaʻu i ka nila, makaʻu lākou e lawe i nā injections. Hiki i nā lāʻau hypoglycemic waha ke hōʻino i ke ake a me nā puʻupaʻa. ʻO ke ʻano kuʻuna o ka insulin injection. Ua komo nā halemai kula kiʻekiʻe he ʻumi ma ka ʻāina i ke aʻo ʻana he 112 lā nui loa o ka hoʻokele insulin ʻole me ka insulin no ka maʻi maʻi maʻi maʻi 427 i loaʻa i ka insulin. ʻO ka ho'ēmiʻana he 0.27, aʻo ka hoʻohaʻahaʻa awelika o ka hui no-needle i hiki i ka 0.61. He 2.25 ka nui o ka nila no ka hui kui ole. Hiki i ka mea maʻi ke loaʻa ka pae hemoglobin maikaʻi aʻe i ka hoʻokele insulin me ka ʻole. ʻO ka nui o ka hoʻomau ʻana he 0 ma hope o 16 mau pule o ka hoʻopaʻa ʻana i ka insulin me ka pono ʻole. ʻO Professor Ji Linong, ka luna o ka 'Oihana o Endocrinology, Beijing People's Hospital, ka luna o ka Diabetes Branch o ka Chinese Medical Association, i'ōleloʻia: I ka hoʻohālikelikeʻia me ka nila-free injection, me ka hoʻohanaʻana i ka nila-free injection e hoʻokomo i ka insulinʻaʻole hiki iā ia ke hoʻomaikaʻi maikaʻi i ke koko koko me ka hoʻonuiʻole i ka pilikia o ka hypoglycemia. Ua hōʻike ʻia nā haʻawina he haʻahaʻa haʻahaʻa ka ʻeha a me ka ʻoluʻolu kiʻekiʻe o ka poʻe maʻi i ka maʻi hoʻomake ʻole i ka insulin. Hoʻemi nui ʻia nā ʻōpala a me nā subcutaneous indurations, e ʻae ana i nā poʻe maʻi e pale i ka makaʻu nila, kahi e hoʻomaikaʻi nui ai i ka mālama koko koko lōʻihi. Me ka hoʻomau mau ʻana a me ka hoʻolaha ʻana o ka ʻenehana injection non- needle-free, e hōʻoia ʻia nā pono o ka mālama glucose palekana a maikaʻi hoʻi i nā mea maʻi.